Create Medic (5187) Q4 2024 earnings summary

Executive summary

• Net sales increased by 3.5% year-over-year to ¥13,030 million for the year ended December 2024.

• Operating profit declined by 13.8% year-over-year to ¥692 million.

• Profit attributable to owners of parent surged 446.0% year-over-year to ¥840 million, reflecting a significant improvement.

• Comprehensive income rose 198.4% year-over-year to ¥1,652 million.

Financial highlights

• Ordinary profit decreased by 14.1% year-over-year to ¥750 million.

• Basic earnings per share increased to ¥95.41 from ¥16.92 year-over-year.

• Total assets grew to ¥20,047 million from ¥15,750 million year-over-year.

• Net assets rose to ¥19,258 million from ¥14,944 million year-over-year.

• Cash and equivalents at period end were ¥5,662 million, up from ¥3,770 million year-over-year.

Outlook and guidance

• Net sales for the year ending December 2025 are forecasted to increase by 4.2% to ¥13,583 million.

• Operating profit is projected to rise 44.7% to ¥1,002 million.

• Profit attributable to owners of parent is expected to decrease by 5.3% to ¥796 million.

• Basic earnings per share forecasted at ¥92.67 for the next fiscal year.